Presenter: James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
0:00
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. At the conclusion of this activity, participants will be able…
Latest Podcasts
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
Le groupe d'intérêt des membres sur la santé des patients 2SLGBTQ+ a collaboré avec projet NUANCES, centre de soins en diversité sexuelle et de genre. Dre Judith Lajeunesse et Charlotte…
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
This podcast discusses two of the most common gender-affirming surgeries - vaginoplasty in a transfeminine patient and top surgery or mastectomy in a trans masculine patient. These are emotionally high…
BS Medicine Episode #623: Less than 140, 130, or 120? Counting down to the optimal systolic blood pressure target
In episode 623, Jamie and James invite Samantha Moe back again to talk about the never-ending debate as to what is the target for systolic blood pressure. We look at…
May 26, 2021
Presenter(s):
James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
Please provide any additional comments (optional).